Literature DB >> 16749548

Factors associated with pulmonary edema in severe scorpion sting patients--a multivariate analysis of 428 cases.

Mounir Bouaziz1, Mabrouk Bahloul, Leila Hergafi, Hatem Kallel, Leila Chaari, Chokri Ben Hamida, Adel Chaari, Hedi Chelly, Noureddine Rekik.   

Abstract

OBJECTIVE: To determine clinical and routine laboratory factors associated with pulmonary edema secondary to scorpion envenomation. DESIGN AND
SETTING: Retrospective study covering 13 years (1990-2002) in the medical Intensive Care Unit of a university hospital (Sfax-Tunisia). PATIENTS: 428 patients older than 3 years who were admitted to the intensive care unit for scorpion envenomation were included in this study. Patients were stratified into two groups according to the presence or absence of pulmonary edema as assessed by a medical committee. MEASUREMENTS AND
RESULTS: The mean (+/- SD) age was 17.5 +/- 17.7 years, ranging from 3 to 76 years. The pulmonary edema group included 294 patients (68.7%). A multivariate analysis found the following factors to be correlated with a pulmonary edema: age less than 5 years (p = 0.04), sweating (p = 0.004), agitation (p = 0.01), leukocytes of 25000 cells/mm3 or more (p = 0.02), and a plasma protein concentration of 72 g/L or more (p < 0.0001). In addition, a plasma protein concentration of 72 g/L or more predicted the presence of pulmonary edema with a sensitivity of 78% a specificity of 88%, a positive predictive value of 93%, and negative predictive value of 64%. Almost 84% of patients having a respiratory rate of > or = 30 breaths/minute associated with agitation and sweating were classified in the pulmonary edema group. This clinical association indicates the presence of pulmonary edema with a specificity of 84.3% and a positive predictive value of 87.5%.
CONCLUSION: In scorpion envenomation patients older than 3 years, the association of a respiratory rate of > or = 30 breaths/minute, agitation, sweating, or the presence of high plasma protein concentrations suggest the presence of pulmonary edema.

Entities:  

Mesh:

Year:  2006        PMID: 16749548     DOI: 10.1080/15563650600584501

Source DB:  PubMed          Journal:  Clin Toxicol (Phila)        ISSN: 1556-3650            Impact factor:   4.467


  6 in total

1.  Scorpion envenomation among children: clinical manifestations and outcome (analysis of 685 cases).

Authors:  Mabrouk Bahloul; Imen Chabchoub; Anis Chaari; Kamilia Chtara; Hatem Kallel; Hassen Dammak; Hichem Ksibi; Hedi Chelly; Noureddine Rekik; Chokri Ben Hamida; Mounir Bouaziz
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

2.  Incidence and impact outcome of hyperglycaemia in severe scorpion envenomed children requiring intensive care admission.

Authors:  Kamilia Chtara; Mabrouk Bahloul; Olfa Turki; Najeh Baccouche; Kais Regaieg; Chokri Ben Hamida; Hedi Chelly; Imen Chabchoub; Anis Chaari; Mounir Bouaziz
Journal:  Intensive Care Med       Date:  2015-07-25       Impact factor: 17.440

Review 3.  Incidence, mechanisms and impact outcome of hyperglycaemia in severe scorpion-envenomed patients.

Authors:  Mabrouk Bahloul; Olfa Turki; Anis Chaari; Mounir Bouaziz
Journal:  Ther Adv Endocrinol Metab       Date:  2018-05-03       Impact factor: 3.565

4.  Predictive Value of Glycemia and Free Fatty Acid Levels upon Admission of Children with Scorpionism in Egypt.

Authors:  Khaled Abdalla Abd-Elbaseer; Eman Ahmed Abd-Elmawgood; H M Qubaisy; Abdel-Rahman Abdel-Hamed El-Saied; Mohammed A A Abdel Naser; Yaser F Abd-Elraheem
Journal:  Am J Trop Med Hyg       Date:  2022-01-10       Impact factor: 3.707

5.  Elevated Cardiac Troponin (cTnI) Levels Correlate with the Clinical and Echocardiographic Evidences of Severe Myocarditis in Scorpion Sting Envenomation.

Authors:  Suresh V Sagarad; Balaram Singh Thakur; S S Reddy; K Balasubramanya; R M Joshi; Sudha Biradar Kerure
Journal:  J Clin Diagn Res       Date:  2012-10

Review 6.  Scorpion sting nephropathy.

Authors:  Stalin Viswanathan; Chaitanya Prabhu
Journal:  NDT Plus       Date:  2011-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.